After the turbulent end of last week, the S&P 500 contracts opened with a bearish price gap on February 1, but began catching up immediately. Upbeat mood prevails today and is related not only to the decline in volatility on Wall Street (previously the VIX index rose significantly due to the short squeeze on some companies), but also to optimism regarding the vaccine. The results provided by AstraZeneca show that the use of a second dose of the vaccine after 3 months increases its effectiveness to 82.4%. AstraZeneca indicates that the possibility of taking the second dose after a relatively long period of time will make it possible to vaccinate a large number of people in the first round and increase its effectiveness in the second.
US500 is clearly bouncing back. Recent correction was the largest since November. Currently, the contract is trading less than 1% from its historical high. Source: xStation5
